Replimune

Replimune

Replimune

Replimune Ltd is an Oxford UKbased developer of oncolytic immunotherapies for the treatment of cancer,
Founded
2015
Raised
$85M
Follow us
Alexa global traffic share
Latest funding
$30,000,000
Venture capital (Series A) - 2015
Team Size
1–10
Employees
the home of AI info

Reviewing Minerva Neurosciences Inc. (NERV)'s and Replimune Group Inc. (NASDAQ:REPL)'s ...